Northern Trust Corp Celldex Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 562,720 shares of CLDX stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

562,720

Previous 545,594 3.14%

Holding current value

$15.2 Million

Previous $20.2 Million 5.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$32.06 - $44.56 $549,059 - $763,134	17,126 Added 3.14%	562,720 $19.1 Million
Q2 2024 Aug 14, 2024	SELL	$32.76 - $42.56 $270,826 - $351,843	-8,267 Reduced 1.49%	545,594 $20.2 Million
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $3.84 Million - $5.66 Million	109,056 Added 24.52%	553,861 $23.2 Million
Q4 2023 Feb 13, 2024	SELL	$22.61 - $40.65 $658,290 - $1.18 Million	-29,115 Reduced 6.14%	444,805 $17.6 Million
Q3 2023 Nov 13, 2023	SELL	$25.45 - $37.46 $352,024 - $518,146	-13,832 Reduced 2.84%	473,920 $13 Million
Q2 2023 Aug 11, 2023	BUY	$30.29 - $38.28 $218,057 - $275,577	7,199 Added 1.5%	487,752 $16.5 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $1.6 Million - $2.18 Million	45,941 Added 10.57%	480,553 $17.3 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $343,666 - $561,395	12,371 Added 2.93%	434,612 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $32,370 - $53,574	-1,426 Reduced 0.34%	422,241 $11.9 Million
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $325,273 - $592,315	-15,867 Reduced 3.61%	423,667 $11.4 Million
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $680,773 - $968,451	-24,630 Reduced 5.31%	439,534 $15 Million
Q4 2021 Feb 08, 2022	BUY	$35.68 - $56.27 $180,219 - $284,219	5,051 Added 1.1%	464,164 $17.9 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $1.36 Million - $2.62 Million	46,850 Added 11.36%	459,113 $24.8 Million
Q2 2021 Aug 13, 2021	BUY	$20.71 - $35.37 $6.32 Million - $10.8 Million	305,057 Added 284.55%	412,263 $13.8 Million
Q1 2021 May 12, 2021	BUY	$16.19 - $29.91 $197,793 - $365,410	12,217 Added 12.86%	107,206 $2.21 Million
Q4 2020 Feb 11, 2021	BUY	$14.99 - $22.75 $99,593 - $151,151	6,644 Added 7.52%	94,989 $1.66 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $299,584 - $471,573	31,045 Added 54.18%	88,345 $1.31 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $37,094 - $308,966	23,040 Added 67.25%	57,300 $744,000
Q1 2020 May 14, 2020	SELL	$1.55 - $3.07 $497 - $985	-321 Reduced 0.93%	34,260 $57,000
Q4 2019 Feb 14, 2020	BUY	$2.11 - $2.8 $10,874 - $14,431	5,154 Added 17.51%	34,581 $78,000
Q3 2019 Nov 13, 2019	BUY	$2.05 - $2.75 $1,084 - $1,454	529 Added 1.83%	29,427 $63,000
Q2 2019 Aug 13, 2019	BUY	$2.43 - $5.09 $1,671 - $3,501	688 Added 2.44%	28,898 $77,000
Q1 2019 May 13, 2019	BUY	$3.45 - $10.35 $97,324 - $291,973	28,210 New	28,210 $139,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Celldex Therapeutics, Inc. Transaction History